FAQ

carboxycinnamic acid bishydroxamide

Known as: m-carboxycinnamic acid bishydroxamide, m-Carboxycinnamic Acid Bishydroxamic Acid, CBHA cpd 
A hybrid polar compound that induces terminal differentiation and/or apoptosis in various transformed cells. It is an inhibitor of histone… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2014
01219982014

Related topics

Related topics

2 relations

Broader (2)

CinnamatesHistone deacetylase inhibitor

Related mentions per year

Related mentions per year

1953-2018
1960198020002020
carboxycinnamic acid bishydroxamide
Histone deacetylase inhibitor
Cinnamates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Epigenetic reprogramming, gene expression and in vitro development of porcine SCNT embryos are significantly improved by a histone deacetylase inhibitor—m-carboxycinnamic acid bishydroxamide (CBHA)
Insufficient epigenetic reprogramming of donor nuclei is believed to be one of the most important causes of low development… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Histone Deacetylase Inhibitor Impairs Plasminogen Activator Inhibitor-1 Expression via Inhibiting TNF-α-Activated MAPK/AP-1 Signaling Cascade
Tumor necrosis factor-(TNF-)-α upregulates plasminogen activator inhibitor-(PAI-) 1 expression in pleural mesothelial cells (PMCs… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
CALL FOR PAPERS Technology Development for Physiological Genomics Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy
Majumdar G, Rooney RJ, Johnson IM, Raghow R. Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to… (More)
  • figure 2
  • figure 3
  • figure 4
  • table 1
  • figure 5
Is this relevant?
2010
2010
Somatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydroxamide, a histone deacetylase inhibitor.
Somatic cell nuclear transfer (SCNT) has shown tremendous potential for understanding the mechanisms of reprogramming and… (More)
Is this relevant?
2005
2005
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
In the present study, we aimed to elucidate the mechanism responsible for the interactive effects of histone deacetylase (HDAC… (More)
Is this relevant?
2000
2000
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.
BACKGROUND Neuroblastoma is a common childhood cancer with a poor overall prognosis. Retinoic acids (RAs) have been studied as a… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.
Inhibitors of histone deacetylase (HDAC) have been shown to have both apoptotic and differentiating effects on various tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.
Hybrid polar compounds (HPCs) have been synthesized that induce terminal differentiation and/or apoptosis in various transformed… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?